$ATEX

DANIELS LESLIE B sold $880K of ATEX

DANIELS LESLIE B sold 10,100 shares of Anterix Inc. (ATEX) at an average of $87.12 ($86.50–$87.31, $0.88M total) across 3 trades over 2026-09-03 to 2026-09-04.

Original reporting
SEC EDGAR · DANIELS LESLIE B
Published Sep 8, 2026, 8:03 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 8, 2026, 8:26 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$ATEX
Neutral
medium confidence
Mentioned
$ATEX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATEXNeutralLow
01

Why it matters

The disclosed sale is modest and unlikely to move the stock significantly, but it adds to the flow of insider activity data.

02

Market read

New insider sale filing; low material impact but useful for monitoring insider sentiment.

03

What to watch

Potential upcoming corporate actions or financing needs not disclosed.

Relevance 5/10Novelty 5/10Timing: filed today

Background

Form 4 filings provide transparent insight into insider trading activity; director sales are monitored by investors for sentiment cues.

Company-level read

Ticker impact

$ATEXNeutralMedium confidence
Context

Director Leslie B. Daniels sold approximately $880K of ATEX shares via open‑market transactions on Sep 3‑4, reducing his stake to 45,977 shares.

Expected impact

Minor downward pressure, likely within normal trading variance.

Evidence & confidence

Form 4 is a primary disclosure; size under $1M and director role suggest low materiality.

Market effects

No broader sector impact; insider sale is company‑specific.

U.S. market only; negligible regional effect.

Not globally relevant.

Counterpoint

The sale could be a routine liquidity move rather than a negative signal.

Key entities

  • Anterix Inc.

    U.S. listed communications infrastructure firm (NASDAQ: ATEX).

  • Leslie B. Daniels

    Director of Anterix Inc. who sold shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATEXHigh

Why is Anterix stock rallying today?

Anterix (ATEX) stock rose 3.4% in pre-market trading after Apple's new iPhones were announced to support Anterix's 900 MHz spectrum for private LTE networks. The company also extended its $250 million share buyback program. The S&P 500, Dow Jones, and Nasdaq all showed gains in pre-market trading.

$ATEXMed

Is Anterix (ATEX) Quietly Reframing Its Connectivity Moat With New 900 MHz FCC Flexibility?

Anterix (ATEX) gained attention after the FCC approved expanded 900 MHz broadband use and granted it a license for satellite testing. This could broaden its network applications and reinforce its investment narrative, though profitability currently relies heavily on noncash spectrum gains. Analysts project $6.9M revenue and $935K earnings by 2028, with a potential 36% downside from current prices.

$ATEXMed

Anterix (ATEX) Q1 2027 Earnings Call Transcript

Anterix (ATEX) reported Q1 2027 revenue of $2M, up from $1.4M YoY, with net income of $240K. Operating expenses decreased to $12.9M. The company has $116M in cash, no debt, and $226.7M left for share repurchases. Management highlighted 12 active deals, spectrum clearing progress, and support for SpaceX's FCC proposal. CFO warned of potential higher costs if spectrum clearing is accelerated.